)
)
NIOX Group Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from NIOX Group Plc
Access all reports
NIOX Group Plc is a medical device company focused on the diagnosis and management of respiratory diseases, with a particular emphasis on asthma. The company's flagship product, NIOX VERO, is a non-invasive, point-of-care device designed for the measurement of fractional exhaled nitric oxide, which is a biomarker for airway inflammation in asthma patients. This device aids healthcare professionals in diagnosing and managing asthma by providing precise FeNO measurements. The company is headquartered in Oxford, United Kingdom, and its shares are listed on the London Stock Exchange.
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
NIOX
Country
🇬🇧 United Kingdom